Vitalhub (TSE:VHI) Upgraded at Stifel Canada

Vitalhub (TSE:VHI) was upgraded by research analysts at Stifel Canada to a “strong-buy” rating in a report released on Tuesday,Zacks.com reports.

A number of other brokerages have also recently commented on VHI. Stifel Nicolaus set a C$15.00 target price on shares of Vitalhub and gave the company a “buy” rating in a report on Wednesday. Royal Bank Of Canada set a C$15.00 price target on shares of Vitalhub and gave the company a “moderate buy” rating in a research report on Thursday, September 18th. Scotiabank boosted their price objective on shares of Vitalhub from C$14.00 to C$14.50 and gave the stock an “outperform” rating in a research note on Friday, June 20th. Raymond James Financial raised their target price on shares of Vitalhub from C$14.50 to C$15.00 and gave the company an “outperform” rating in a research note on Tuesday, August 12th. Finally, TD Securities lifted their target price on shares of Vitalhub from C$15.00 to C$16.00 and gave the company a “buy” rating in a report on Monday, August 11th. Two equities research analysts have rated the stock with a Strong Buy rating and seven have issued a Buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of C$14.86.

Vitalhub Stock Up 0.7%

TSE VHI opened at C$10.70 on Tuesday. The firm has a market capitalization of C$672.28 million, a PE ratio of 133.75, a P/E/G ratio of 1.18 and a beta of 0.62. The stock’s 50 day moving average is C$11.89 and its 200 day moving average is C$11.34. Vitalhub has a twelve month low of C$8.50 and a twelve month high of C$14.64.

Insider Activity

In related news, Director Danny Matlow sold 150,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the completion of the sale, the director owned 520,001 shares of the company’s stock, valued at C$6,630,012.75. This trade represents a 22.39% decrease in their ownership of the stock. Also, Director Steve Garrington sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the completion of the transaction, the director owned 60,000 shares of the company’s stock, valued at approximately C$774,000. The trade was a 25.00% decrease in their ownership of the stock. 18.57% of the stock is currently owned by insiders.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.